These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33281098)

  • 1. Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance.
    Bacci M; Lorito N; Smiriglia A; Morandi A
    Trends Cancer; 2021 Mar; 7(3):198-213. PubMed ID: 33281098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
    Ray U; Roy SS
    FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming in triple-negative breast cancer.
    Wang Z; Jiang Q; Dong C
    Cancer Biol Med; 2020 Feb; 17(1):44-59. PubMed ID: 32296576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer cell metabolism: Rewiring the mitochondrial hub.
    Oliveira GL; Coelho AR; Marques R; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of lipid metabolism alterations in Cancer stem cells.
    Yi M; Li J; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Peng S; Li X; Xiong W; Li G; Xiang B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):118. PubMed ID: 29907133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer.
    Liu Q; Luo Q; Halim A; Song G
    Cancer Lett; 2017 Aug; 401():39-45. PubMed ID: 28527945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Plasticity: The Role of mRNA Translation.
    Lee LJ; Papadopoli D; Jewer M; Del Rincon S; Topisirovic I; Lawrence MG; Postovit LM
    Trends Cancer; 2021 Feb; 7(2):134-145. PubMed ID: 33067172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How cancer cells remodel lipid metabolism: strategies targeting transcription factors.
    Jeong DW; Lee S; Chun YS
    Lipids Health Dis; 2021 Nov; 20(1):163. PubMed ID: 34775964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the RAS-dependent chemoresistance: The Warburg connection.
    Serna-Blasco R; Sanz-Álvarez M; Aguilera Ó; García-Foncillas J
    Semin Cancer Biol; 2019 Feb; 54():80-90. PubMed ID: 29432815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid metabolism reprogramming and its potential targets in cancer.
    Cheng C; Geng F; Cheng X; Guo D
    Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers.
    Ye J; Zou M; Li P; Liu H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818805997. PubMed ID: 30444190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Alterations of Metabolism Associated with Resistance to Chemotherapy.
    Ghasemi F; Farkhondeh T; Samarghandian S; Ghasempour A; Shakibaie M
    Curr Mol Med; 2024; 24(7):856-866. PubMed ID: 37350008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.
    Gao Y; Shen JK; Milane L; Hornicek FJ; Amiji MM; Duan Z
    Curr Med Chem; 2015; 22(11):1335-47. PubMed ID: 25666804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability.
    Sirois I; Aguilar-Mahecha A; Lafleur J; Fowler E; Vu V; Scriver M; Buchanan M; Chabot C; Ramanathan A; Balachandran B; Légaré S; Przybytkowski E; Lan C; Krzemien U; Cavallone L; Aleynikova O; Ferrario C; Guilbert MC; Benlimame N; Saad A; Alaoui-Jamali M; Saragovi HU; Josephy S; O'Flanagan C; Hursting SD; Richard VR; Zahedi RP; Borchers CH; Bareke E; Nabavi S; Tonellato P; Roy JA; Robidoux A; Marcus EA; Mihalcioiu C; Majewski J; Basik M
    Mol Cancer Res; 2019 Dec; 17(12):2492-2507. PubMed ID: 31537618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy.
    Wang Z; Liu P; Chen Q; Deng S; Liu X; Situ H; Zhong S; Hann S; Lin Y
    Curr Drug Targets; 2016; 17(8):853-64. PubMed ID: 25777274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of tamoxifen resistance and lipid reprogramming in breast cancer.
    Hultsch S; Kankainen M; Paavolainen L; Kovanen RM; Ikonen E; Kangaspeska S; Pietiäinen V; Kallioniemi O
    BMC Cancer; 2018 Aug; 18(1):850. PubMed ID: 30143015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance.
    Kuo CY; Ann DK
    Cancer Commun (Lond); 2018 Jul; 38(1):47. PubMed ID: 29996946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in therapeutic strategies based on cancer lipid metabolism.
    Diao XY; Lin T
    Thorac Cancer; 2019 Sep; 10(9):1741-1743. PubMed ID: 31328418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.